Business, Policy & Funding
Breaking news on precision medicine business, policy & funding.
Meta-Analysis Questions FDA Warning on Secondary Cancer Risks With CAR T-Cell Therapies
Researchers analyzed two dozen studies and found similar rates of second primary cancers in patients receiving CAR T-cell and standard therapies.
Vir Biotechnology Completes Licensing Deal With Sanofi for Three T-Cell Engager Programs
Vir gained exclusive worldwide rights to HER2-targeted, PSMA-targeted, and EGFR-targeted T-cell engager assets.
BridgeBio Discontinues Development of Gene Therapy for Congenital Adrenal Hyperplasia
The company said newly released Phase I/II study data for BBP-631 indicated the program did not merit further capital investment.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
GenomOncology, Precipio Partner on Myeloid Test Reporting
GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.